Skip to content
10-K

Annual Report

BIOAGE LABS, INC. BIOA

0001193125-26-120873

← back to feed
Filed
Mar 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 44.38M sh
Shares Diluted FY 2025 · Dec 31, 2025 35.93M sh
Shares Diluted FY 2025 · Dec 31, 2024 10.73M sh
Capex FY 2025 · Dec 31, 2025 $719K
Capex FY 2025 · Dec 31, 2024 $366K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$81.63M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$51.52M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $2.5M
Short Term Debt FY 2025 · Dec 31, 2025 $2.65M
Short Term Debt FY 2025 · Dec 31, 2024 $6M
Cash And Equivalents FY 2025 · Dec 31, 2025 $188.89M
Cash And Equivalents FY 2025 · Dec 31, 2024 $354.35M
Stockholders Equity FY 2025 · Dec 31, 2025 $272.05M
Stockholders Equity FY 2025 · Dec 31, 2024 $323.13M
Stockholders Equity FY 2025 · Dec 31, 2023 −$173.4M
Current Liabilities FY 2025 · Dec 31, 2025 $20.14M
Current Liabilities FY 2025 · Dec 31, 2024 $27.78M
Total Liabilities FY 2025 · Dec 31, 2025 $22.84M
Total Liabilities FY 2025 · Dec 31, 2024 $35.11M
Current Assets FY 2025 · Dec 31, 2025 $286.79M
Current Assets FY 2025 · Dec 31, 2024 $357.1M
Total Assets FY 2025 · Dec 31, 2025 $294.89M
Total Assets FY 2025 · Dec 31, 2024 $358.23M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.24
Eps Diluted FY 2025 · Dec 31, 2024 −$6.63
Eps Basic FY 2025 · Dec 31, 2025 −$2.24
Eps Basic FY 2025 · Dec 31, 2024 −$6.63
Sga Expense FY 2025 · Dec 31, 2025 $27.81M
Sga Expense FY 2025 · Dec 31, 2024 $19.16M
Rd Expense FY 2025 · Dec 31, 2025 $73.97M
Rd Expense FY 2025 · Dec 31, 2024 $59.04M
Net Income FY 2025 · Dec 31, 2025 −$80.61M
Net Income FY 2025 · Dec 31, 2024 −$71.11M
Operating Income FY 2025 · Dec 31, 2025 −$92.78M
Operating Income FY 2025 · Dec 31, 2024 −$78.19M
Revenue FY 2025 · Dec 31, 2025 $9M
Revenue FY 2025 · Dec 31, 2024 $0